<DOC>
	<DOCNO>NCT00465803</DOCNO>
	<brief_summary>The purpose study assess patient compliance DuoTrav versus concomitant administration Timolol 0.5 % plus TRAVATAN patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>A Phase IIIb Study DuoTrav Treat Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Adult patient openangle glaucoma ocular hypertension ; Other protocoldefined inclusion criterion may apply . Visual acuity bad 0.60 ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Open-angle glaucoma ocular hypertension</keyword>
</DOC>